Ningetinib

Ningetinib · Sunshine Lake Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ningetinib, covering 2022-06-22 to 2022-10-27. Get the full timeline:

Most recent: Clinical Trial Update: Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations [Phase 2]